CG dinucleotide transitions in the factor IX gene account for about half of the point mutations in hemophilia B patients: a Seattle series
- PMID: 2066105
- DOI: 10.1007/BF00204177
CG dinucleotide transitions in the factor IX gene account for about half of the point mutations in hemophilia B patients: a Seattle series
Abstract
Hemophilia B is due to multiple molecular defects in the factor IX gene. Over 80% of mutations are single base substitutions. By amplification and direct sequencing, 51 single base substitutions were found in the transcribed sequence of the factor IX genes of patients from 50 distinct families with hemophilia B. These include 30 mutations in 29 families not previously reported by us; of these, 12 are novel, i.e., not previously published in other series. Of the 51 substitutions in our overall series 23 (45%) occurred as C-to-T or G-to-A transitions at 11 sites within CG dinucleotides. It is estimated that CG transitions occur from one to two orders of magnitude more frequently than mutations in nucleotides that are not within a CG pair. More than one family had identical defects for 6 of the CG mutations. At 4 of these sites, most patients had different haplotypes compatible with distinct mutations. Non-CG-type mutations occurred throughout the coding regions with only one mutation in more than one family. The latter included 7 families with a 397 Ile-to-Thr defect that all share a rare haplotype, suggesting a common ancestor.
Similar articles
-
[Methylation of the factor IX gene--a basic reason for the mutation causing hemophilia B].Mol Biol (Mosk). 1995 Jan-Feb;29(1):71-90. Mol Biol (Mosk). 1995. PMID: 7723765 Russian.
-
Mutations causing hemophilia B: direct estimate of the underlying rates of spontaneous germ-line transitions, transversions, and deletions in a human gene.Am J Hum Genet. 1990 Aug;47(2):202-17. Am J Hum Genet. 1990. PMID: 2198809 Free PMC article.
-
Molecular characterization of hemophilia B in North Indian families: identification of novel and recurrent molecular events in the factor IX gene.Haematologica. 2004 Dec;89(12):1498-503. Haematologica. 2004. PMID: 15590401
-
Assessing the underlying pattern of human germline mutations: lessons from the factor IX gene.FASEB J. 1992 Jul;6(10):2767-74. doi: 10.1096/fasebj.6.10.1634040. FASEB J. 1992. PMID: 1634040 Review.
-
Human germline mutation in the factor IX gene.Mutat Res. 2001 Nov 1;487(1-2):1-17. doi: 10.1016/s0921-8777(01)00108-2. Mutat Res. 2001. PMID: 11595404 Review.
Cited by
-
Hemophilia B: molecular pathogenesis and mutation analysis.J Thromb Haemost. 2015 Jul;13(7):1184-95. doi: 10.1111/jth.12958. Epub 2015 May 18. J Thromb Haemost. 2015. PMID: 25851415 Free PMC article. Review.
-
Genetic and Bioinformatic Strategies to Improve Diagnosis in Three Inherited Bleeding Disorders in Bogotá, Colombia.Genes (Basel). 2021 Nov 18;12(11):1807. doi: 10.3390/genes12111807. Genes (Basel). 2021. PMID: 34828413 Free PMC article.
-
Recurrent mutations in the factor IX gene: founder effect or repeat de novo events. Investigation of the German haemophilia B population and review of de novo mutations.Hum Genet. 1993 Aug;92(1):40-8. doi: 10.1007/BF00216143. Hum Genet. 1993. PMID: 8365725
-
Germ line origins of de novo mutations in hemophilia B families.Hum Genet. 1994 Sep;94(3):299-302. doi: 10.1007/BF00208288. Hum Genet. 1994. PMID: 8076948
-
Screening for nonsense mutations in patients with severe hemophilia A can provide rapid, direct carrier detection.Hum Genet. 1992 Apr;89(1):88-94. doi: 10.1007/BF00207049. Hum Genet. 1992. PMID: 1349567